Laura Polastro

Inhibition of RANK signaling in breast cancer induces an anti-tumor immune response orchestrated by CD8+ T cells

Clara Gomez‐Aleza, Bastien Nguyen, Guillermo Yoldi et al. · Nature Communications · 2020 · 92 citations · Full text

Medicine, Immunology, Oncology +17

Implementation of a remote symptom monitoring pathway in oncology care: analysis of real-world experience across 33 cancer centres in France and Belgium

Maria Alice Franzoi, Arlindo R. Ferreira, Antoine Lemaire et al. · The Lancet Regional Health - Europe · 2024 · 36 citations · Full text

Nursing, Health Informatics, Oncology +17

PARP inhibitors (PARPi) prolongation after local therapy for oligo-metastatic progression in relapsed ovarian cancer patients

Thibault Gauduchon, Maria Kfoury, Domenica Lorusso et al. · Gynecologic Oncology · 2023 · 35 citations

Medicine, Oncology, Pharmacology +17

Results of the Belgian expanded access program of eribulin in the treatment of metastatic breast cancer closely mirror those of the pivotal phase III trial

Philippe Aftimos, Laura Polastro, Lieveke Ameye et al. · European Journal of Cancer · 2016 · 27 citations

Medicine, Oncology, Breast Oncology +9

Cemiplimab in recurrent cervical cancer: Final analysis of overall survival in the phase III EMPOWER-Cervical 1/GOG-3016/ENGOT-cx9 trial

Ana Oaknin, Bradley J. Monk, Andréia Cristina de Melo et al. · European Journal of Cancer · 2025 · 19 citations

Medicine, Gynecology, Oncology +11